Optimi Health (NASDAQ:OPTH – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a research report issued to clients and investors on Saturday.
Other analysts also recently issued reports about the company. Zacks Research raised Optimi Health to a “hold” rating in a research report on Thursday, May 28th. Weiss Ratings assumed coverage on shares of Optimi Health in a research report on Thursday, May 21st. They issued a “sell (d-)” rating on the stock. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Optimi Health has a consensus rating of “Reduce”.
Get Our Latest Research Report on OPTH
Optimi Health Price Performance
Read More
- Five stocks we like better than Optimi Health
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Optimi Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Optimi Health and related companies with MarketBeat.com's FREE daily email newsletter.
